Fertin Pharma has achieved ISO 13485 certification for the development and production of medical devices at our facility in Denmark. This includes our Class 3 medical device, the Calcium Carbonate Chewable Tablet, which is classified in the same category as in-demand products subject to strict regulations under ISO 13485. Our medical device expertise combined with

Fertin Pharma A/S (“Fertin Pharma”), a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, today announced the closing of its acquisition by Philip Morris International Inc. (PMI) (NYSE: PM) for an enterprise value of DKK 5.1 billion (approximately USD 820 million[1] ). “We are excited to

Vejle, 1 July, 2021 EQT announced today that it has agreed to sell Fertin Pharma, a specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International (PMI) (NYSE: PM). With headquarters in Vejle, Denmark, Fertin Pharma is a leading specialist CDMO in innovative oral and intra-oral delivery

This article was originally published in Danish by the University of Southern Denmark (SDU) and adapted by Fertin Pharma. Read the original article here: Mie er junior specialist i lægemiddelbranchen (mitsdu.dk) Subject knowledge is indispensable, but personality and social skills also play a significant role when a company needs to find the right employee. Mie

IP – a vital framework to create healthier living Every year in April, the global community celebrates World Intellectual Property Day. At Fertin, we recognize the importance of putting Intellectual Property (IP) in the limelight. We believe that IP is a vital framework and powerful tool to advance new ideas and to stimulate cutting-edge research

It has been more than one year since the COVID-19 pandemic hit the world and changed nearly every aspect of our existence. We are adjusting to a new reality in most parts of our lives, as businesses as well as individuals. Although there is still undoubtedly uncertainty in the days ahead, we would like to

During the 2021 edition of PLMA online trade show to be held on February 3 and 4, 2021, Fertin Pharma will present its ready-to-license caffeine chewing gum. Together with its subsidiary Tab Labs, Fertin Pharma will present this innovative product, which is a quick and convenient delivery system for that all-important caffeine-induced pick-me-up at the

Fertin Pharma is very excited about the recent launch of our new Enterprise Resource Planning (ERP) system, which is based on the latest SAP 4/Hana platform. The new system, with more than 1,400 different SAP tiles, supports our long-term growth strategy and strong commitment to customers and partners. It enables us to increase our responsiveness

Peter Halling has been appointed CEO of Fertin Pharma and will join in August 2020. Peter brings extensive experience from working in international environments of production companies in complex and contract-driven markets. He most recently served as an Executive Vice President at Döhler Group but prior to that held various roles at Ingredion and Novozymes.

Succeeds Tom Hoeltgen, who is set to retire in December, 2020 Fertin Pharma, a leading contract development and manufacturing organization (CDMO), has appointed John Stephen as CEO of Tab Labs, its Vancouver-based subsidiary. Stephen has been active in the dietary and supplement field for over 30 years. Fertin, which has four decades of experience and